Africa Holguin | Microbiology | Best Researcher Award

Published on by Academic Achievements

Dr. Africa Holguin | Microbiology | Best Researcher Award

Dr. Africa Holguin | Microbiology – Investigador at Instituto Ramón y Cajal de Investigación Sanitaria – IRYCIS, Spain

Dr. Africa Holguín is a globally respected virologist and the Head of the HIV-1 Molecular Epidemiology Laboratory at IRYCIS – Hospital Ramón y Cajal in Madrid, Spain. Her work has significantly advanced the global understanding of HIV genetic variability, antiretroviral resistance, and viral surveillance. She has been a leading figure in molecular virology research for over two decades and is especially recognized for her studies on non-B HIV-1 subtypes, viral quasispecies, and the epidemiological patterns of drug resistance mutations. With over 5,300 citations and more than 100 publications, Dr. Holguín is a key contributor to the global HIV research community and a scientific leader in infectious disease molecular diagnostics.

Academic Profile:

ORCID

Scopus

Google Scholar

Education:

Dr. Holguín completed her graduate studies in biological sciences with a specialization in virology and molecular biology. Her academic training emphasized molecular diagnostics and viral genomics, providing her with the tools to engage in complex viral surveillance projects. She later deepened her specialization in infectious diseases through advanced research training, equipping her to lead cross-disciplinary studies on the molecular epidemiology of HIV and other RNA viruses.

Experience:

With over 25 years of experience in clinical virology and molecular epidemiology, Dr. Holguín has led numerous high-impact national and international research projects. Her role as the head of a specialized research laboratory has allowed her to supervise a range of HIV-related studies, including drug resistance surveillance, viral genetic analysis, and epidemiological modeling. She collaborates with global health bodies and research consortia and has worked extensively on patient cohorts including immigrants, children, and treatment-naïve populations. She also provides expert input for public health decision-making and clinical guideline development.

Research Interests:

Dr. Holguín’s research focuses on the molecular evolution of HIV-1, especially non-B subtypes, and how natural genetic polymorphisms affect treatment outcomes. She investigates antiretroviral resistance, viral quasispecies, and genetic recombination events that impact diagnosis and therapy. Her interests extend to real-world applications, such as viral load testing accuracy and genotype interpretation systems. Recently, she has contributed to molecular surveillance of SARS-CoV-2, showcasing her adaptability and leadership in emerging infectious disease research.

Awards:

Dr. Holguín has received multiple accolades and recognitions for her contributions to virology and public health. Her work has influenced global HIV treatment strategies, and she has participated in advisory panels and policy-shaping discussions at the national and international level. She has also received institutional recognition for her mentorship and leadership in scientific research and has played a key role in developing Spain’s HIV molecular monitoring infrastructure.

Selected Publications 📚:

  1. 📘 “Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review” – The Lancet Infectious Diseases, 2019 – Cited by 457
  2. 📗 “Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype” – PLoS Medicine, 2005 – Cited by 393
  3. 📙 “Pol gene quasispecies of HIV: mutations associated with drug resistance in untreated patients” – Journal of Virology, 1995 – Cited by 274
  4. 🧬 “Evolution of SARS-CoV-2 structural proteins from the start of the pandemic to September 2020” – Viruses, 2021 – Cited by 113
  5. 📒 “High prevalence of HIV-1 subtype G and natural polymorphisms among immigrants in Madrid” – AIDS, 2002 – Cited by 98
  6. 📕 “Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis in immigrant sex workers in Spain” – Journal of Medical Virology, 2004 – Cited by 83
  7. 📓 “Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes” – AIDS Reviews, 2006 – Cited by 81

Conclusion:

Dr. Africa Holguín’s remarkable research record, impactful collaborations, and long-term leadership in the field of HIV molecular epidemiology make her a strong candidate for the Best Researcher Award. Her commitment to scientific excellence, especially in the areas of viral resistance and subtype diversity, has contributed to meaningful advancements in clinical care and global health policy. With a strong citation record, consistent publication output, and a multidisciplinary approach to emerging infectious diseases, Dr. Holguín exemplifies the qualities of an outstanding researcher whose work continues to shape the future of virology and public health.

 

 

Dr. Israa Malli | Microbiology | Best Researcher Award

Published on by Academic Achievements

Dr. Israa Malli | Microbiology | Best Researcher Award

Dr. Israa Malli | Microbiology – Associate Professor at ksauhs, Saudi Arabia

Dr. Israa Abdullah Malli is an accomplished academic and researcher in the field of microbiology with a focus on infectious diseases and medical education. She holds the position of Assistant Professor of Microbiology at a prominent health sciences university, where she is deeply involved in teaching, research, and mentorship. Dr. Malli’s work emphasizes the intersection of microbiology, epidemiology, and biotechnology, contributing significantly to both academic and scientific communities. She has made notable advancements in understanding microbial behavior, antibiotic resistance, and the role of probiotics in health. Additionally, her leadership roles in academic committees reflect her commitment to shaping the next generation of health professionals.

Profile Verified:

Orcid | Scopus

Education:

Dr. Malli’s educational background is rooted in prestigious institutions. She earned her Ph.D. in Microbiology from Howard University, Washington, DC, in 2017, where her research focused on the molecular mechanisms of bacterial resistance. She holds a Master’s in Biotechnology from The Catholic University of America, Washington, DC, and a Bachelor of Medical Laboratories from King Abdul-Aziz University. She also completed her Master’s in Medical Education from King Saud Bin-Abdul-Aziz University for Health Sciences in 2020, further enhancing her ability to contribute to educational advancements in medical sciences.

Experience:

With over a decade of experience, Dr. Malli has held various academic and administrative roles. She has been serving as Assistant Professor of Microbiology and Assistant Dean for Academic Affairs at King Saud Bin-Abdul-Aziz University for Health Sciences. Her responsibilities include designing and coordinating microbiology courses, delivering lectures, and providing one-on-one mentorship to students. In addition, she has served in leadership capacities such as the In-Charge of the Assessment Unit and Deputy Chair of the Department of Basic Medical Sciences, where she helped enhance the academic framework of the university. Her leadership in academic and research committees has shaped several key initiatives aimed at improving student outcomes and fostering a culture of scientific inquiry.

Research Interests:

Dr. Malli’s research interests primarily focus on the molecular biology of infectious diseases, specifically the mechanisms behind antibiotic resistance and the use of probiotics for improving patient health. Her research into the role of reactive oxygen species in bacterial disinfection processes has contributed to advancing the understanding of bacterial resistance mechanisms, particularly in foodborne pathogens like Salmonella. Dr. Malli also explores the potential of probiotics in mitigating health complications in cancer patients. Her interdisciplinary research combines microbiology, biotechnology, and medical education to address critical global health challenges, particularly those concerning antimicrobial resistance.

Awards:

Dr. Malli has received numerous accolades throughout her academic career, underscoring her contributions to research and education. Notably, she has been recognized for her mentorship, with several of her students winning prestigious awards at research forums. Her efforts in advancing medical research have been acknowledged with Certificates of Appreciation for her role in scientific committees and research forums. These honors reflect her dedication to fostering an environment of excellence and scholarly achievement within the academic community. Her leadership in educational innovation and student mentorship has also been widely recognized.

Publications:

Dr. Malli has authored several impactful research articles in peer-reviewed journals, contributing significantly to her field. Here are some of her notable publications:

  1. “Application of Eugenol to Control Salmonella in Poultry” (Veterinary Sciences, 2023) 🐔 This article explores the use of eugenol as a potential agent to control Salmonella in poultry, providing insights into natural antimicrobial interventions.
  2. “Sublethal Chlorine Concentration and Antibiotic Resistance in Salmonella” (Applied Microbiology, 2024) 🧫 In this study, Dr. Malli investigates the relationship between sublethal chlorine concentrations and the development of antibiotic resistance in Salmonella, contributing to the understanding of resistance mechanisms in food safety.
  3. “Reactive Oxygen Species Mediate the Bactericidal Activity of Chlorine Against Salmonella” (Current Microbiology, 2024) 💡 This research delves into the bactericidal properties of chlorine, showing how reactive oxygen species play a critical role in eliminating Salmonella.
  4. “Probiotic Potential of Bifidobacterium in Cancer Patients” (Acta Microbiologica Bulgarica, 2024) 🦠 Dr. Malli’s research on probiotics highlights their therapeutic potential in cancer patients, showing the significance of gut microbiota in cancer management.
  5. “From Inflammation to Cancer: Genetic Polymorphisms and Gastric Cancer” (Springer, 2021) 🧬 This work examines genetic polymorphisms and their connection to gastric cancer susceptibility, offering insights into molecular pathways involved in cancer development.
  6. “Host-Targeted Antivirals and HIV-1 Infection Mechanisms” (Preprints, 2021) 🦠 In this article, Dr. Malli discusses how host-targeted antivirals can inhibit HIV-1 infection by affecting key viral mechanisms, adding to the broader field of antiviral research.
  7. “Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma” (Journal of Global Infectious Diseases, 2024) 🦠 This publication provides a comprehensive meta-analysis of how co-infection with hepatitis B and C viruses contributes to the risk of liver cancer, influencing future clinical approaches to hepatitis treatment.

Conclusion:

Dr. Israa Abdullah Malli’s academic and research contributions are impressive and deserving of the Best Researcher Award. Her work in microbiology, specifically her research on antimicrobial resistance and probiotics, has added significant value to the scientific community. Additionally, her commitment to education and mentorship has left a lasting impact on students and fellow researchers alike. As she continues to expand her research and foster interdisciplinary collaborations, Dr. Malli is poised to contribute even more to global health challenges, particularly in the areas of infectious diseases and cancer. Her work exemplifies the power of academic rigor combined with compassionate mentorship, making her a highly deserving nominee for this prestigious award.

 

 

 

 

Bashar İbrahim | Bacteriology | Best Researcher Award

Published on by Academic Achievements

Dr. Bashar İbrahim | Bacteriology | Best Researcher Award

Dr. Bashar İbrahim | Bacteriology – Assistant Professor at Suleyman demirel university, Turkey

Dr. Bashar Ibrahim is a distinguished microbiologist with a profound impact on the field of medical microbiology, infectious diseases, and antimicrobial resistance. With a research career spanning over a decade, he has contributed significantly to understanding bacterial pathogenesis, biofilm formation, and alternative antimicrobial therapies. His work on quorum sensing inhibition, novel antibacterial agents, and infectious disease diagnostics has gained international recognition, making him a leading figure in microbiological research. As an Assistant Professor at Süleyman Demirel University, he has been instrumental in shaping the next generation of microbiologists while simultaneously advancing cutting-edge research.

Professional Profile

Google Scholar  |  Orcid

Education

Dr. Ibrahim pursued his Ph.D. in Medical Microbiology at Eskişehir Osmangazi University, where he conducted groundbreaking research on the prevalence of Campylobacter jejuni in infectious diarrhea. Prior to his doctorate, he completed his Master’s degree in Microbiology at Gazi University, focusing on pre- and post-transplant HEV prevalence in acute leukemia patients undergoing allogeneic transplantation. His academic journey began with a Bachelor’s degree in Biology from Mosul University, where he developed a keen interest in microbial pathogenesis and infectious diseases. His educational background has provided him with a strong foundation for his impactful research in microbiology and immunology.

Experience

Dr. Ibrahim has an extensive academic and research career, currently serving as an Assistant Professor in the Department of Pharmaceutical Microbiology at Süleyman Demirel University. His expertise in microbiology extends beyond academia, as he has actively contributed to research projects and industry collaborations. He plays a vital role in a TÜBİTAK-funded project focused on developing new antimicrobial strategies, demonstrating his ability to lead and innovate in the field. Additionally, he has been involved in scientific peer review, mentoring graduate students, and curriculum development, ensuring that his contributions extend beyond research to education and professional development.

Research Interests

Dr. Ibrahim’s research revolves around infectious disease microbiology, antimicrobial resistance, quorum sensing inhibition, and biofilm formation. His studies have explored natural product-based antimicrobials, investigating their potential to combat drug-resistant pathogens. His work on COVID-19-associated microbial infections has been particularly impactful, shedding light on the microbiological complications of viral diseases. Additionally, he has contributed to pharmaceutical microbiology, focusing on the development of novel antimicrobial formulations and sterility standards for pharmaceutical applications. His research continues to push boundaries in the fight against antimicrobial resistance, making significant strides toward innovative solutions.

Awards

Dr. Ibrahim’s exceptional contributions to microbiological research were recognized when he received the Science Honor Award from the International Academy of Sciences in 2020. This prestigious award acknowledges his groundbreaking research in antibacterial resistance and microbial pathogenesis. His ability to lead high-impact studies and secure research funding has further solidified his reputation as an influential scientist in the global research community.

Publications 📚

1️⃣ Ibrahim B., Reis A., Arin U.E., et al. (2025) – Investigation of the antibacterial activity of Rhamnus cathartica L. and its anti-QS potential on Pseudomonas aeruginosa PAO1 🦠. Natural Product Research.
2️⃣ Ghafil J.A., Al-Sudani S.F.K., Ibrahim B., et al. (2025) – Relationship between biofilm formation of Pseudomonas aeruginosa and susceptibility to rifaximin and ofloxacin 🔬. Pakistan Journal of Pharmaceutical Sciences.
3️⃣ Kurt A.A., Ibrahim B. (2024) – Preparation of New Generation Natural Repellent Formulations From Essential Oils: From Basic Research to Technological Development 🌿. Journal of Cosmetic Science. 📖
4️⃣ Bayraktar N., Elali K., Pehlivan V., Ibrahim B., et al. (2024) – Examination of D-Dimer, Fibrinogen, CRP, and LDH Levels in Serum of Patients with COVID-19 Diabetes Mellitus 🏥. Proceedings of the National Academy of Sciences India Section B – Biological Sciences.
5️⃣ Ibrahim B., Dereli F.T., Erzurumlu Y., et al. (2023) – Anti-Quorum Sensing Activity of Vitis vinifera L. Seed Extract on Some Bacteria: A Greener Alternative Against Antimicrobial Resistance 🍇. Erwerbs-Obstbau Journal.
6️⃣ Öztürk A., Bozok T., Erdoğan M., Ibrahim B., et al. (2023) – COVID-19-associated pulmonary aspergillosis (CAPA): Identification of Aspergillus species and determination of antifungal susceptibility profiles 🦠. Folia Microbiologica.
7️⃣ Bayraktar M., Çetintaş İ., Ibrahim B., et al. (2023) – Evaluation of Microbial Agents in Patients with Chronic Suppurative Otitis Media 🎧. Gevher Nesibe Journal of Medicine and Health Sciences.

Conclusion

Dr. Bashar Ibrahim stands as a remarkable researcher in medical microbiology, pharmaceutical sciences, and infectious disease research. His extensive contributions to antimicrobial resistance, quorum sensing inhibition, and infectious disease microbiology have made a significant impact on the scientific community. With a strong publication record, leadership in research projects, and recognition through prestigious awards, he has established himself as a leading authority in his field. His dedication to advancing microbiological research, mentoring students, and contributing to pharmaceutical sciences makes him an outstanding candidate for the Best Researcher Award. By continuing to expand his research collaborations and focusing on translational applications, Dr. Ibrahim is set to make even greater strides in global scientific innovation. 🚀

Ibrar Khan | Microbiology | Best Researcher Award

Published on by Academic Achievements

Dr. Ibrar Khan | Microbiology | Best Researcher Award

Assistant Professor at Abbottabad University of Science and Technology, Pakistan

 Dr. Ibrar Khan is a dedicated microbiologist and academician specializing in applied microbiology, biological control, and bioremediation. With extensive research experience, he has contributed significantly to microbial biotechnology, environmental microbiology, and industrial microbiology. Currently serving as an Assistant Professor at Abbottabad University of Science and Technology (AUST), Pakistan, Dr. Khan continues to inspire students and researchers through his innovative work in microbiology.

Profile

Google scholar

Education🎓 

Dr. Ibrar Khan holds a Ph.D. in Microbiology from Ocean University of China (2012-2015), where he focused on microbial biotechnology and bioremediation. He also earned an M.Phil. in Microbiology from Quaid-I-Azam University, Islamabad (2010-2012), and a BS (Hons) in Microbiology from Hazara University, Mansehra, Pakistan (2005-2009). His academic journey reflects his commitment to excellence in microbiological research.

Experience🏋️ 

As an Assistant Professor at AUST since 2016, Dr. Khan has been involved in teaching and research in microbiology. Previously, he served as an Assistant Professor at Hazara University, Mansehra, and as a Junior Research Assistant at Quaid-I-Azam University. He has also worked as a microbiologist at Ayub Teaching Hospital, gaining practical experience in clinical microbiology. His extensive teaching and research experience have enabled him to mentor numerous postgraduate students.

Research Interest📝

Dr. Khan’s research focuses on applied microbiology, bioremediation, phage therapy, and metabolic engineering. His work addresses biological control of bacterial diseases, environmental pollution degradation, biomolecule production, and industrial microbiology. His contributions have led to advancements in microbial technology for sustainable solutions in agriculture and environmental management.

Awards & Grants🏆

Dr. Khan’s achievements include a Gold Medal for his BS (Hons) in Microbiology, a Merit Scholarship for his M.Phil., and a Ph.D. Scholarship under the China Scholarship Council (CSC). He has also received several research grants, such as the NRPU Project for bacteriophage-based control of rice bacterial blight and the ORIC-AUST grant for developing essential oil-based disinfectants for COVID-19.

Publications📃

Dr. Khan has published extensively in high-impact journals. Some notable publications include:

“Microbial biosynthesis and secretion of l-malic acid and its applications”
Cited by: 172
Year: 2016

“Mycoremediation of heavy metal (Cd and Cr)–polluted soil through indigenous metallotolerant fungal isolates”
Cited by: 151
Year: 2019

“A review on remediation technologies for heavy metals contaminated soil”
Cited by: 106
Year: 2020

“An overview of the plant-mediated synthesis of zinc oxide nanoparticles and their antimicrobial potential”
Cited by: 88
Year: 2020

“Mycoremediation: a treatment for heavy metal-polluted soil using indigenous metallotolerant fungi”
Cited by: 68
Year: 2019

“Medicinal plants: a repository of antiviral metabolites”
Cited by: 66
Year: 2017

“Extraction and screening of bioactive compounds with antimicrobial properties from selected species of mollusk and crustacean”
Cited by: 63
Year: 2014

“Calcium malate overproduction by Penicillium viticola 152 using the medium containing corn steep liquor”
Cited by: 60
Year: 2014

“Microbes and environment: global warming reverting the frozen zombies”
Cited by: 54
Year: 2020

“Myogenesis and analysis of antimicrobial potential of silver nanoparticles (AgNPs) against pathogenic bacteria”
Cited by: 52
Year: 2023

“Chaetomium endophytes: a repository of pharmacologically active metabolites”
Cited by: 52
Year: 2016

“CRISPR/Cas system: a game-changing genome editing technology, to treat human genetic diseases”
Cited by: 47
Year: 2019

“Isolation and Characterization of Heavy Metal Resistant Fungal Isolates from Industrial Soil in China”
Cited by: 38
Year: 2016

“High-level production of calcium malate from glucose by Penicillium sclerotiorum K302”
Cited by: 37
Year: 2013

“Endophytic fungi associated with Taxus fuana (West Himalayan Yew) of Pakistan: potential bio-resources for cancer chemopreventive agents”
Cited by: 32
Year: 2016

“Prevalence and Association of Obesity with Self‐Reported Comorbidity: A Cross‐Sectional Study of 1321 Adult Participants in Lasbela, Balochistan”
Cited by: 26
Year: 2017

 

Conclusion🌟

Dr. Ibrar Khan is a highly qualified researcher with a strong academic and research profile, making him a strong candidate for the Best Researcher Award. His contributions to applied microbiology, environmental bioremediation, and phage therapy are notable. With further advancements in high-impact publications, international collaborations, and patent development, he can further solidify his standing as a leading researcher in microbiology.

Dr. Fizza Khalid | Microbiology Award | Best Researcher Award

Published on by Academic Achievements

Dr. Fizza Khalid | Microbiology Award | Best Researcher Award 

Dr. Fizza Khalid, Dr Sulaiman Al-Habib Medical Diagnostic Laboratory, Saudi Arabia

Fizza Khalid is a dedicated Microbiologist with a robust educational background and extensive experience in laboratory research and clinical analysis. She holds a Ph.D. in Medical Microbiology from the University of Health Sciences in Lahore, where her research focused on the characterization of drug-resistant Acinetobacter baumannii strains. With a solid foundation in both M.Phil. and M.Sc. degrees in Medical Microbiology and Medical Technology, respectively, Fizza has developed expertise in microbial resistance and quality control in clinical settings. Currently serving as the Deputy Head of the Clinical Research Committee and Specialized Lab Supervisor at MD LAB, Dr. Sulaiman AlHabib Medical Group in Saudi Arabia, she excels in collaborative research, training healthcare professionals, and ensuring compliance with regulatory standards. Fizza is committed to advancing microbiological science and improving patient outcomes through her meticulous approach and passion for research, making her a valuable asset to any healthcare organization.

Professional Profile:

ORCID 

Summary of Suitability for Best Researcher Award:

Dr. Fizza Khalid is an exemplary candidate for the Best Researcher Award, distinguished by her extensive educational background and significant contributions to the field of microbiology. With a Ph.D. in Medical Microbiology from the University of Health Sciences, her research has primarily focused on the characterization of drug-resistant strains of Acinetobacter baumannii, a critical issue in healthcare today.

Education:

  • Ph.D. in Medical Microbiology
    University of Health Sciences, Lahore (2016–2023)
    Thesis: Characterization of locally isolated Acinetobacter baumannii strains for drug resistance and biofilm formation.
  • M. Phil in Medical Microbiology
    University of Health Sciences, Lahore (2012–2014)
    Thesis: In-vitro efficacy of Polymyxin B with Rifampin, Colistin, and Doxycycline against extensively drug-resistant Acinetobacter baumannii.
  • M.Sc. in Medical Technology
    University of Health Sciences, Lahore (2008–2010)
    Thesis: Frequency of extended spectrum beta-lactamase enzymes in the clinical isolate of Salmonella typhi.
  • B.Sc. in Medical Laboratory Technology
    University of the Health Sciences, Lahore (2005–2007).

Work Experience:

  • Deputy Head of Clinical Research Committee/Specialized Lab Supervisor Microbiology
    MD LAB, Dr. Sulaiman AlHabib Medical Group, KSA (September 2023 – Present)

    • Collaborate with scientists and healthcare professionals.
    • Ensure compliance with regulatory agencies (CAP, CBAHI, JCI).
    • Conduct research and write manuscripts for publication.
    • Prepare and present data at international conferences.
    • Facilitate junior researchers and promote clinical research culture through workshops.
    • Train healthcare professionals in study design and scientific writing.
    • Maintain laboratory records and prepare reports.
    • Train and supervise laboratory personnel.
  • Senior Lab Technologist
    Dr. Sulaiman AlHabib Medical Group, KSA (January 2017 – February 2022)

    • Review, revise, and create standard operating protocols for the Clinical Microbiology Lab.
    • Perform laboratory analysis of clinical specimens and interpret results.
    • Monitor accuracy and quality of clinical microbiology testing.
    • Ensure compliance with safety regulations and quality control standards.

Publication top Notes:

Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan

High prevalence of carbapenem-resistant Acinetobacter baumannii associated respiratory tract infections in Pakistani hospitals.

A Cyclic-di-GMP signalling network regulates biofilm formation and surface associated motility of Acinetobacter baumannii 17978

Methylglyoxal: Antimicrobial activity against blood culture isolates of Salmonella Typhi and other Gram negative rods.

In-vitro efficacy of polymyxin B with rifampin, colistin and doxycycline against extensively drug resistant Acinetobacter baumannii